Skip to main content

MoneyWorks4Me

NGL Fine-Chem informs about analyst meet

29 Sep 2022 Evaluate

Pursuant to Regulation 30(6) of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, NGL Fine-Chem has informed that the officials of the company will be interacting with Analyst/ Investor on 30th September, 2022. The copy of the Investor Presentation has been uploaded on the Stock Exchanges and on the Company’s website www.nglfinechem.com.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1880.90
Dr. Reddys Labs. 1377.00
Cipla 1393.00
Lupin 1980.00
Zydus Lifesciences 1191.00
View more..